Literature DB >> 20178643

Significance of occult neoplastic cells on tumor metastasis: a case report of gastric cancer.

Shinkichi Sato1, Masaya Mukai.   

Abstract

BACKGROUND: Occult neoplastic cells (ONCs) are the tumor cells floating in the lymph node sinuses, distant from the primary tumor, and supposed to be one of most reliable marker of prognosis.
METHODS: We report here the case of a 52-year-old woman with a gastric cancer associated by numerous ONCs.
RESULTS: Postoperative examination of the stomach disclosed an advanced, poorly differentiated adenocarcinoma with frequent lymph node metastases. In addition to ONCs and occasional micrometastases, focal aggregates of ONCs, one of the possible intermediate lesions between the ONCs and the usual metastases, are also observed.
CONCLUSIONS: In the present case, at least some of ONCs seem to form the microaggregates of tumor cells in lymph nodes, anchor in the sinuses, and grow up to the large tumorous lesion. Even if most of the ONCs were trapped and disappeared under the influence of tumor immunity, the detection of ONCs could be one of the reliable clues to estimate the prognosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20178643      PMCID: PMC2843646          DOI: 10.1186/1746-1596-5-14

Source DB:  PubMed          Journal:  Diagn Pathol        ISSN: 1746-1596            Impact factor:   2.644


  13 in total

Review 1.  Bone marrow "micrometastases" of epithelial tumors: detection and clinical relevance.

Authors:  P Müller; G Schlimok
Journal:  J Cancer Res Clin Oncol       Date:  2000-11       Impact factor: 4.553

2.  Enzyme-labeled antibodies: preparation and application for the localization of antigens.

Authors:  P K Nakane; G B Pierce
Journal:  J Histochem Cytochem       Date:  1966-12       Impact factor: 2.479

3.  Enzyme-labeled antibodies for the light and electron microscopic localization of tissue antigens.

Authors:  P K Nakane; G B Pierce
Journal:  J Cell Biol       Date:  1967-05       Impact factor: 10.539

4.  Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.

Authors:  S Braun; K Pantel; P Müller; W Janni; F Hepp; C R Kentenich; S Gastroph; A Wischnik; T Dimpfl; G Kindermann; G Riethmüller; G Schlimok
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

Review 5.  Detection of occult metastasis in patients with breast cancer.

Authors:  D Hawes; A M Neville; R J Cote
Journal:  Semin Surg Oncol       Date:  2001-06

Review 6.  Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancer.

Authors:  S Braun; R Rosenberg; S Thorban; N Harbeck
Journal:  Semin Surg Oncol       Date:  2001-06

7.  Significance of nodal metastatic tumor characteristics in nodal metastasis and prognosis of patients with invasive ductal carcinoma of the breast.

Authors:  Takahiro Hasebe; Satoshi Sasaki; Shigeru Imoto; Atsushi Ochiai
Journal:  Cancer Sci       Date:  2003-02       Impact factor: 6.716

8.  Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal, and gastric cancer.

Authors:  Masaya Mukai; Shinkichi Sato; Hisao Nakasaki; Takayuki Tajima; Yuuki Saito; Noboru Nishiumi; Masayuki Iwasaki; Yutaka Tokuda; Kyoji Ogoshi; Hiroshi Inoue; Hiroyasu Makuuchi
Journal:  Oncol Rep       Date:  2004-01       Impact factor: 3.906

9.  Criteria for predicting the recurrence and metastasis of stage I and II gastric cancer without lymph node metastasis.

Authors:  Masaya Mukai; Shinkichi Sato; Tomomi Kimura; Nobukazu Komatsu; Hiromi Ninomiya; Hisao Nakasaki; Kyouji Ogoshi; Hiroyasu Makuuchi
Journal:  Oncol Rep       Date:  2004-07       Impact factor: 3.906

10.  Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.

Authors:  Masaya Mukai; Isao Ito; Sayuri Mukoyama; Takayuki Tajima; Yuuki Saito; Hisao Nakasaki; Shinkichi Sato; Hiroyasu Makuuchi
Journal:  Oncol Rep       Date:  2003 Jul-Aug       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.